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To determine whether task failure during incremental exercise to exhaustion (IE) is
principally due to reduced neural drive and increased metaboreflex activation eleven
men (22 ± 2 years) performed a 10 s control isokinetic sprint (IS; 80 rpm) after a short
warm-up. This was immediately followed by an IE in normoxia (Nx, PIO2:143mmHg) and
hypoxia (Hyp, PIO2:73mmHg) in random order, separated by a 120min resting period.
At exhaustion, the circulation of both legs was occluded instantaneously (300mmHg)
during 10 or 60 s to impede recovery and increase metaboreflex activation. This was
immediately followed by an IS with open circulation. Electromyographic recordings were
obtained from the vastus medialis and lateralis. Muscle biopsies and blood gases were
obtained in separate experiments. During the last 10 s of the IE, pulmonary ventilation,
VO2, power output and muscle activation were lower in hypoxia than in normoxia, while
pedaling rate was similar. Compared to the control sprint, performance (IS-Wpeak) was
reduced to a greater extent after the IE-Nx (11% lower P < 0.05) than IE-Hyp. The
root mean square (EMGRMS) was reduced by 38 and 27% during IS performed after
IE-Nx and IE-Hyp, respectively (Nx vs. Hyp: P < 0.05). Post-ischemia IS-EMGRMS values
were higher than during the last 10 s of IE. Sprint exercise mean (IS-MPF) and median
(IS-MdPF) power frequencies, and burst duration, were more reduced after IE-Nx than
IE-Hyp (P < 0.05). Despite increased muscle lactate accumulation, acidification, and
metaboreflex activation from 10 to 60 s of ischemia, IS-Wmean (+23%) and burst duration
(+10%) increased, while IS-EMGRMS decreased (−24%, P < 0.05), with IS-MPF and
IS-MdPF remaining unchanged. In conclusion, close to task failure, muscle activation
is lower in hypoxia than in normoxia. Task failure is predominantly caused by central
mechanisms, which recover to great extent within 1min even when the legs remain
ischemic. There is dissociation between the recovery of EMGRMS and performance. The
reduction of surface electromyogram MPF, MdPF and burst duration due to fatigue is
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associated but not caused by muscle acidification and lactate accumulation. Despite
metaboreflex stimulation, muscle activation and power output recovers partly in ischemia
indicating that metaboreflex activation has a minor impact on sprint performance.
Keywords: electromyography, EMG, exhaustion, fatigue, high-intensity, hypoxia, lactate, performance
INTRODUCTION
Muscle fatigue has been defined as “any exercise-induced
reduction in the ability to exert muscle force or power,
regardless of whether the task can be sustained (Bigland-
Ritchie and Woods, 1984), that can be reversed by rest”
(Gandevia, 2001). The mechanisms leading to task failure may
involve physiological processes at neural (central fatigue) or
muscular levels (peripheral fatigue), with failure distal to the
neuromuscular junction included in the “peripheral” component.
It has been suggested that the rate of muscle fatigue development
is regulated by the central nervous system (CNS) with feedback
from the type III and IV muscle afferents (Amann and Dempsey,
2008), which sense metabolite accumulation, particularly H+,
lactate, and ATP (Light et al., 2008). Type III/IV muscle afferents
have been reported to inhibit corticospinal drive (Amann and
Dempsey, 2008; Rossman et al., 2012; Kennedy et al., 2015), with
greater inhibitory effect on extensor than flexor muscles (Martin
et al., 2006). However, whether metabolite accumulation and
the expected metaboreflex stimulation impair muscle activation
and limit peak power during whole-body sprint exercise remains
unknown.
During whole-body exercise in severe acute hypoxia (FIO2 <
0.115, or altitude above 4500m) the level of peripheral fatigue
at exhaustion seems lower, indicating that central mechanisms,
likely linked to reduced brain oxygenation (Rasmussen et al.,
2010), predominate over local mechanisms in determining the
cessation of exercise (Amann et al., 2007). In agreement with
this hypothesis, an instantaneous increase of the inspired O2
fraction (FIO2) from 0.21 to 1.00 does not eliminate muscle
fatigue at the end of an incremental exercise test performed at
sea level (Calbet et al., 2003a). In contrast, during constant-
intensity or incremental exercise to exhaustion in severe hypoxia
(PIO2 ≈ 75mmHg), muscle fatigue is swiftly relieved by mild
hyperoxic gas or room air (Kayser et al., 1994; Calbet et al.,
2003a,b; Amann et al., 2007). These findings led to the concept
that during incremental exercise to exhaustion in normoxia, task
Abbreviations: ADP, Adenosine diphosphate; ATP, Adenosine triphosphate;
CNS, Central nervous system; d.w., Dry weight; DEXA, Dual-energy x-ray
absorptiometry; EMG, Surface electromyogram; EMGRMS, Root mean square of
the EMG; FIO2, Inspired oxygen fraction; HR, Heart rate; HRmax, Maximal
heart rate; Hyp, Hypoxia; Hypb, session in hypoxia with biopsies taken; IE,
Incremental exercise to exhaustion; IS, Isokinetic sprint; MPF, Mean power
frequency;MdPF,Median power frequency;MVC,Maximal voluntary contraction;
Nx, Normoxia; Nxb, Session in normoxia with biopsies taken; PaO2, Arterial
oxygen pressure; PCr, Phosphocreatine; PIO2, Inspired O2 pressure; RMS, root
mean square; RMSNz, Normalized root mean square; VE, Minute ventilation;
VO2, Oxygen consumption; VO2max, Maximal oxygen uptake; VO2peak, Peak
oxygen uptake; Wpeak-i, Instantaneous peak power output; Wmax, Peak power
output at exhaustion during the incremental exercise test; Wmean, mean power
output during the 10 s sprints; w.w., wet weight; TAI, Total activation index.
failure is most likely caused by peripheral mechanisms while
central mechanisms prevail in severe hypoxia (Calbet et al.,
2003a; Amann et al., 2007). In support, peripheral fatigue, as
assessed via decreases in potentiated quadriceps twitch force
2min after constant-intensity exercise to exhaustion, was lower
when the exercise was performed in severe hypoxia than in
normoxia (Amann et al., 2007). Nevertheless, this observation
was not accompanied by an assessment ofmusclemetabolites and
obviates the fact that reduced potentiated quadriceps twitch force
may occur without reduction of peak power output (Fernandez-
del-Olmo et al., 2013; Hureau et al., 2014). Moreover, the
recovery process starts as early as muscle contraction ceases,
and given the fast kinetics of phosphocreatine re-synthesis at
the end of exercise (Bogdanis et al., 1996; Dawson et al.,
1997; Yoshida et al., 2013), most of the recovery has already
occurred within the first 2min post-exercise (Sargeant and
Dolan, 1987; Froyd et al., 2013). Also, muscle fatigue is task-
specific (Gandevia, 2001), implying that a procedure using
a similar pattern of movement, and hence recruitment of
neural pathways, is expected to be more sensitive to detect
fatigue.
In this context, every possible combination of effects and
interpretation of results has been reported in regard to the
contribution of central and peripheral mechanisms to muscle
fatigue after dynamic contractions in normoxia (Sidhu et al.,
2009, 2012; Marcora and Staiano, 2010; Fernandez-del-Olmo
et al., 2013) and hypoxia (Amann et al., 2007; Goodall et al.,
2010; Millet et al., 2012). Some of these discrepancies can
be attributed to the fact that neural mechanisms of muscle
fatigue are task-specific (Sidhu et al., 2012), to different levels
of input from type III and IV muscle afferents (Sidhu et al.,
2012), and to methodological limitations (Rodriguez-Falces et al.,
2013; Héroux et al., 2015; Bachasson et al., 2016). Although the
inhibition of type III and IV muscle afferents has been shown to
attenuate muscle fatigue in certain exercise models (Sidhu et al.,
2014), whether type III and IV muscle afferent input contributes
to reduce exercise performance by a central mechanism remains
controversial (Millet et al., 2009, 2012; Marcora, 2010; Amann
et al., 2013a; Kennedy et al., 2015). Part of the discrepancies may
be due to the fact that type III and IV muscle afferent discharge
cannot be directly measured during whole-body exercise in
humans, combinedwith the difficulty in interpreting the effects of
intrathecal fentanyl when this drug differently alters ventilation,
arterial O2 content, arterial PaCO2, heart rate and mean arterial
blood pressure, depending on the exercise intensity, exercise
duration, and the study population (Dempsey et al., 2014; Olson
et al., 2014; Poon and Song, 2015). Thus, we decided to explore
the role of III/IV muscle afferents on exercise performance
(peak power output) using a completely different experimental
approach.
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The main aim of this investigation was to determine whether
task failure during an incremental exercise to exhaustion is
principally due to central mechanisms that cause a reduction
in neural activation, modulated by the level of oxygenation.
This hypothesis has been previously examined but with different
procedures (Kayser et al., 1994; Amann et al., 2007, 2013b)
which did not include measurements of muscle metabolites or
performance immediately after exhaustion. Another aim was
to determine if increased afferent feedback from metabolite
accumulation in an exhausted muscle has a negative influence
on sprint performance by reducing neural activation, as assessed
through electromyogram (EMG) recordings.
We aimed to test these two hypotheses: (i) task failure during
incremental exercise to exhaustion in hypoxia occurs with lower
levels of muscle activation compared to normoxia, and (ii)
increased afferent feedback from III and IV muscle afferents
impairs sprint performance.
METHODS
Subjects
Eleven healthy men (age: 21.5 ± 2.0 years, height: 174 ±
8 cm, body mass: 72.3 ± 9.3 kg, body fat: 16.1 ± 4.9%,
VO2max: 51 ± 5mL.kg
−1.min−1) agreed to participate in this
investigation. Before volunteering, subjects received full oral
and written information about the experiments and possible
risks associated with participation. Written consent was obtained
from each subject. The study was performed by the Helsinki
Declaration and was approved by the Ethical Committee of the
University of Las Palmas de Gran Canaria (CEIH-2010-01 and
CEIH-2009-01).
General Overview
This study was a part of a larger project that included
several experiments designed to address the mechanisms
limiting whole-body exercise performance in humans. The
results focusing on O2 transport and muscle metabolism have
been published (Calbet et al., 2015; Morales-Alamo et al.,
2015). Body composition was determined by dual-energy x-
ray absorptiometry (DEXA) (Hologic QDR-1500, Hologic Corp.,
software version 7.10,Waltham,MA) (Calbet et al., 1997), during
the familiarization sessions. The leg muscle mass was calculated
from the DEXA scans using Wang’s et al. model (Wang et al.,
1999).
The experimental protocol is summarized in Figure 1, and
an example of the electromyographic recordings from one
subject is given in Figure 2. On the experimental days, subjects
reported to the laboratory at 08.00 h. after an overnight fast from
22.00 h. The subjects performed an incremental exercise test to
exhaustion in normoxia (PIO2: ∼143mmHg) or acute hypoxia
(PIO2: ∼73mmHg, Altitrainer200, SMTEC, Switzerland), in
random order and separated by a 120min rest. Before the exercise
test, bilateral cuffs were placed around the thighs and connected
to a rapid cuff inflator (SCD10, Hokanson E20 AG101, Bellevue,
USA). The test started with a warm-up (2min at 50 W + 2min
100W + 1min at 160W) followed by 4.5min of slow unloaded
pedaling. This was followed by a 30 s rest period while the
subjects became ready to sprint at the 5th minute after the end
of the warm-up. The volunteers were requested to sprint as
hard and fast as possible during 10 s with the ergometer set in
isokinetic mode and at 80 rpm (Excalibur Sport 925900, Lode,
Groningen, The Netherlands). This sprint was used as a control
sprint and was always performed in normoxia. Five minutes
later, the incremental exercise began. For the test in normoxia,
the load was increased by 30 W every 2min until exhaustion,
starting from an initial load of 80W. In hypoxia, the incremental
test started from 60 W, and the load was increased by 20 W
every 2min until exhaustion. Exhaustion during the incremental
exercise tests was defined by the subject stopping pedaling or
dropping pedaling rate below 50 rpm during 5 s, despite strong
verbal encouragement. At exhaustion, the cuffs were inflated
at maximal speed and pressure (i.e., 300mmHg) to completely
and instantaneously occlude the circulation (ischemia). This
prevented any increase of oxygenation during the recovery and
caused anoxia within 3–5 s of the application of the occlusion
as reported elsewhere (Morales-Alamo et al., 2015). A limitation
of previous studies was that the impact of the early recovery
could not be accounted for (Marcora and Staiano, 2010; Coelho
et al., 2015), and certainly some recovery occurs during the
time elapsed between the end of the exercise and the start of
the sprint. To circumvent this limitation we applied complete
ischemia during the recovery and we used short (10 s) and long
(60 s) ischemia periods. We surmised that peripheral fatigue
would be exacerbated by the prolonged ischemia at the end of
an incremental exercise to exhaustion.
The incremental exercise test in normoxia and hypoxia ended
with two different periods of ischemia of 10 or 60 s, during which
the subjects breathed normoxic gas. Following a countdown, the
subject performed a 10 s isokinetic sprint as hard and fast as
possible while the ergometer was set at 80 rpm. The cuffs were
always instantaneously deflated at the beginning of the post-
ischemia sprints. In the unfatigued state, peak power increases
with pedaling rate, but peak power is less affected by pedaling rate
in the fatigued state (Beelen and Sargeant, 1991). Importantly, the
difference in peak power between the fatigued and unfatigued
state increases the higher the pedaling rate used in the control
sprint (unfatigued) (Beelen and Sargeant, 1991). Thus, to avoid
the limitations associated with varying pedaling rates sprints were
performed in isokinetic mode at 80 rpm, a pedaling rate that
allows maximal power output in the fatigued state (Beelen and
Sargeant, 1991).
A few weeks later, the IEs were repeated in two
additional experimental sessions; 1 day in normoxia (Nxb,
PIO2: ∼143mmHg) and the other in hypoxia (Hypb,
PIO2: ∼73mmHg; “b” indicates biopsy session). In the Nxb
session, after 10min rest in the supine position, a muscle biopsy
was obtained from the m. vastus lateralis with local anesthesia
(lidocaine 2%, 2ml), using the Bergstrom technique with suction
(Bergstrom, 1962). This biopsy was obtained with the needle
pointing distally with 45◦ inclination (Guerra et al., 2011). An
additional incision was performed before the beginning of the
exercise in the contralateral leg. Afterward, the incisions were
covered with a transient plaster, and a cuff was placed around the
left leg. The subjects then sat on the cycle ergometer and resting
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FIGURE 1 | Experimental protocol. The experimental day started with a warm-up followed by 4.5min of slow unloaded pedaling and a 30 s resting phase, while the
subjects became ready to perform the first sprint (isokinetic, 10 s at 80 rpm) at the 5th minute after the end of the warm-up. This sprint was used as a control sprint
and was always performed in normoxia. Five minutes later, an incremental exercise to exhaustion began in normoxia (PIO2: ∼143mmHg) or acute hypoxia
(PIO2: ∼73mmHg). The order of the incremental exercise test was randomized. Between the two incremental exercise tests, the subjects were allowed to rest during
120min. At the end of the incremental exercise test, bilateral cuffs were inflated at maximal speed and pressure (i.e., 300mmHg) to occlude completely and
instantaneously the circulation (ischemia) of the legs. The incremental exercise test in normoxia and hypoxia ended with an ischemia period of 10 s on one experimental
day and 60 s on another day. The order of the duration of the ischemia period was randomized. At the end of the ischemia period, the subjects performed a 10 s
isokinetic sprint as hard and fast as possible (80 rpm) while the cuffs were always instantaneously deflated at the beginning of the post-ischemia sprints.
measurements were performed. Two minutes later, the IE was
begun as described above. At exhaustion, the cuff was inflated
instantaneously at 300mmHg, and a biopsy was taken exactly
10 s after the end of the incremental exercise test. The biopsy
needle was introduced perpendicular to the thigh. This biopsy
was followed by a final biopsy at 60 s with the needle pointing
proximally (45◦ inclination). In the Hypb session, essentially the
same procedures were applied. All biopsies were immediately
frozen in liquid nitrogen and stored at −80◦C. Hypb and Nxb
sessions were performed in random order.
Power Output, Oxygen Uptake and
Hemoglobin Oxygen Saturation
Power output during the sprint was reported as instantaneous
peak power output (Wpeak-i) and mean power output (Wmean)
during the 10 s duration of the sprint. Oxygen uptake was
measured with a metabolic cart (Vmax N29; Sensormedics,
Yorba Linda, California, USA), calibrated before each test
according to the manufacturer instructions, with high-grade
calibration gasses (Carburos Metálicos, Las Palmas de Gran
Canaria, Spain). Respiratory variables were analyzed breath-by-
breath and averaged every 20 s during the incremental exercise
tests. The highest 20-s averaged VO2 recorded in normoxia
was taken as the VO2max. The same criterion was applied
to determine the VO2peak in hypoxia. Hemoglobin oxygen
saturation (SpO2) was determined with a finger pulse oximeter
(OEM III module, 4549-000, Plymouth, MN).
Muscle Metabolites
From each muscle biopsy, 30mg of wet tissue were freeze-
dried, cleaned and powdered with a manual mortar on ice.
Subsequently, the samples were suspended in 0.5M HClO4 and
centrifuged at 15,000 g at 4◦C for 15min. The supernatant was
neutralized with KHCO3 2.1M. ATP, phosphocreatine (PCr),
creatine, pyruvate and lactate concentrations were enzymatically
determined in neutralized extracts by fluorometric analysis
(Lowry and Passonneau, 1972; Morales-Alamo et al., 2013).
Electromyography
Electrical muscle activation was monitored using surface
electromyography (EMG). EMG signals were continuously
recorded from the vastus medialis and vastus lateralis. Before the
application of the EMG electrodes the skin surface was carefully
shaved and wiped with alcohol to reduce skin impedance. Bipolar
single differential electrodes were placed longitudinally on the
muscles following the SENIAM recommendations (Merletti and
Hermens, 2000) and taped to the skin to minimize movement
artifacts. The reference electrode was placed on the skin over
the acromion. The position of the electrodes was marked on the
skin with indelible ink, and these references were used for precise
electrode placement on repeated experiments.
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FIGURE 2 | Power output and EMG of a representative subject. Schematic representation of the power output (upper panels), raw EMG (2nd row), rectified
EMG (3rd row) and rectified and smoothed EMG (lower panels), during the control sprint, last 6 s of the incremental exercise (IE) in normoxia (Nx), subsequent 10-s
isokinetic sprint at 80 rpm (normoxia), IE in hypoxia (Hyp) and subsequent 10-s isokinetic sprint at 80 rpm (normoxia). The connected vertical arrows indicate the
duration of the ischemia period, which in this example was 10 s.
The EMG signals were acquired using a 16-channel recording
system (Myomonitor IV, Delsys Inc., Boston, MA) at a sampling
rate of 1000Hz using rectangular shaped (19.8mm wide and
35mm long) bipolar surface electrodes with 1 × 10mm 99.9%
Ag conductors, and with an inter-conductor distance of 10mm
(DE-2.3 Delsys Inc.). The EMG data were filtered with a high-
pass filter of 20Hz and a low-pass filter of 450Hz using a fifth-
order Butterworth filter. The system has an input impedance
of > 1015 per 0.2pF of input capacitance, a common mode
rejection ratio of >80 dB, signal-to-noise ratio <1.2µV, and
a pre-amplifier gain 1000V/V ±1%. Each pedal revolution
was detected using an electrogoniometer (Goniometer Biosignal
Sensor S700 Joint Angle Shape Sensor; Delsys Inc. Boston) fixed
on the left knee and sampled at 500Hz. EMG and jointmovement
were simultaneously recorded by a portable device (Myomonitor
IV, Delsys Inc. Boston) and wirelessly transmitted to a computer
(EMGWorks Wireless application and EMGWorks Acquisition
3.7.1.3; Delsys, Inc. Boston).
The EMG signal corresponding to each muscle contraction
was analyzed using code developed “in house” (Matlab R2012b,
MathWorks, Natick, MA, USA). The EMG recordings were full-
wave rectified and to provide an index of muscle activation,
the amplitude characteristics were analyzed via average RMS of
a 25-ms moving window for the duration of the burst. Burst
onset and offset detection were determined using 20% of the
maximal EMGRMS activity of each burst as a reference (Baum
and Li, 2003; Hug and Dorel, 2009; Torres-Peralta et al., 2014),
rather than a mean threshold value from 15 consecutive bursts
(Ozgünen et al., 2010). This approach yielded the same result
as direct simple visual discrimination with 100% detection of all
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bursts. The EMGRMS recorded during the last minute of a 2min
80 W load (in normoxia) was used to normalize the remaining
EMGRMS data. Besides, we defined a total activity index during
the sprint (TAI) as TAI = EMGRMS × burst duration (ms) ×
number of pedal strokes during the sprint. The total activity
index is similar to the integrated EMG signal, but was computed
separately for each burst and excluded the baseline EMG between
burst (Torres-Peralta et al., 2014). The TAI recorded during the
last minute of a 2min 80 W load (in normoxia) was used to
normalize the rest of the TAI values.
The mean (MPF) and median (MdPF) power spectrum
frequencies were calculated using the Fast Fourier Transform
(Solomonow et al., 1990). All variables were reported as the mean
values of the pedal strokes recorded during the last 10 s of the
incremental exercise or the 10 s sprints. EMG variables responded
similarly during the four control sprints. Therefore, to reduce
EMG variability the four control sprints were averaged. EMG
data are reported separately for vastus medialis and lateralis, and
also as the average of the two muscles. Since the incremental
exercise tests in normoxia and hypoxia were repeated, the mean
of each pair was used in further analysis to represent either
normoxia or hypoxia.
Statistics
Normal distribution of variables was checked with the Shapiro-
Wilks test. A repeated-measures ANOVA with FIO2 condition
(normoxia vs. hypoxia) and occlusion duration (10 vs. 60 s)
was used to analyze the responses observed during the sprints.
Pairwise comparisons at specific time points were performedwith
Student t-tests, and adjusted for multiple comparisons using the
Holm–Bonferroni method. Values are reported as the mean ±
standard deviation (unless otherwise stated). P ≤ 0.05 was
considered statistically significant. All statistical analyses were
performed using SPSS v.15.0 for Windows (SPSS Inc., Chicago,
IL) and Excel 2011 (Microsoft, Redmond, WA, USA).
RESULTS
Incremental Exercise
Compared to normoxia, Wmax, pulmonary ventilation,
respiratory rate, heart rate and VO2peak were reduced during
the last 10 s of exercise in hypoxia. Additional information
regarding the respiratory and cardiovascular responses to the
IE can be found elsewhere (Calbet et al., 2015; Morales-Alamo
et al., 2015). The ergospirometric variables corresponding to the
last 10 s of incremental exercise are reported in Table 1, together
with the corresponding electromyographic responses.
Muscle Fatigue
Compared to the control sprints, post-IE sprint performance was
reduced (32–46%, P < 0.05; Figure 3) as previously reported
(Morales-Alamo et al., 2015). Sprint Wpeak-i was 11% lower
following post-IE in normoxia than hypoxia. Similar effects were
observed in Wmean. Sprint performance was improved after
ischemic recovery.Wpeak-i andWmean were 11 and 23% higher,
respectively, following 60 than 10 s of occlusion (P < 0.05), as
previously reported (Morales-Alamo et al., 2015).
TABLE 1 | Ergospirometric and electromyographic responses during the
last 10 s of the incremental exercise to exhaustion in normoxia (PIO2 ≈
143mmHg) and severe hypoxia (PIO2 ≈ 73mmHg).
Normoxia Hypoxia P
FIO2 (%) 20.8±0.1 10.8±0.1 <0.001
SpO2(%) 93.1±4.4 64.6±4.6 <0.001
Wmax (W) 259.2±32.0 170.1±21.0 <0.001
VO2peak (l.min
−1 ) 3.62±0.37 2.41±0.29 <0.001
VE (l.min
−1 ) 143.5±19.5 123.8±22.5 <0.001
RR (breaths.min−1 ) 60.2±7.6 53.8±7.0 <0.001
HR (beats.min−1 ) 185.4±6.0 175.1±9.0 <0.001
PETO2(mmHg) 113.2±2.3 58.6±2.8 <0.001
PETCO2(mmHg) 32.1±2.6 27.5±2.1 <0.001
RER 1.15±0.03 1.35±0.11 <0.001
VCO2(l.min
−1 ) 4.12±0.49 3.23±0.41 <0.001
Pedaling rate (rpm) 56.7±7.4 55.4±5.9 0.5
VM RMSraw (µV) 134.2±60.1 113.3±48.9 <0.05
VL RMSraw (µV) 103.0±30.9 88.9±30.9 0.12
Average RMSraw (µV) 121.0±37.7 101.1±33.7 <0.01
VM RMSNz (A.U.) 219.1±77.6 182.3±45.5 <0.05
VL RMSNz (A.U.) 193.7±76.4 165.0±62.4 0.07
Average RMSNz (A.U.) 206.4±61.2 173.7±41.8 <0.05
VM TAINz (A.U.) 289.5±109.6 222.6±88.1 <0.001
VL TAINz (A.U.) 246.5±102.2 187.5±73.1 <0.05
Average TAINz (A.U.) 268.0±80.1 205.0±68.2 <0.001
VM MPF (Hz) 84.2±18.4 89.6±18.0 0.13
VL MPF (Hz) 84.1±18.6 89.6±17.8 0.13
Average MPF (Hz) 84.2±18.5 89.6±17.9 0.13
VM MdPF (Hz) 68.6±12.3 73.3±14.8 <0.05
VL MdPF (Hz) 68.5±12.5 73.0±14.6 <0.05
Average MdPF (Hz) 68.6±12.4 73.1±14.7 <0.05
VM Burst (ms) 401.9±51.7 362.5±55.9 0.12
VL Burst (ms) 401.4±55.2 368.3±55.7 0.10
Average Burst (ms) 401.7±49.4 365.4±52.8 0.10
FIO2, inspiratory oxygen fraction; SpO2, hemoglobin saturation in capillary blood
measured by pulse oximetry; Wmax, power output at exhaustion; VO2, oxygen
consumption; VE , pulmonary ventilation; RR, respiratory rate; HR, heart rate; PETO2, end-
tidal O2 pressure; PETCO2, end-tidal CO2 pressure; RER, respiratory exchange ratio;
VCO2, CO2 production; rpm, revolutions per minute; VL, vastus lateralis; VM, vastus
medialis; RMSraw, raw root mean square; RMSNz, normalized root mean square; TAINz,
Normalized total activation index (arbitrary units, A.U.); MPF, mean power frequency;
MdPF, median power frequency; Burst, burst duration; Average, mean of VM and VL.
EMG responses
Vastus Lateralis EMGs
Figure 2 depicts an example of the EMG recordings during
one experimental day. During the last 10 s of the incremental
exercise to exhaustion the raw (average of the two muscles) and
normalized RMS were 16% lower in hypoxia than in normoxia
(P < 0.05) (Table 1). The average normalized TAI was also
lower (23%) in hypoxia than in normoxia (P < 0.001). The
median frequency was 6% lower in normoxia than hypoxia (P <
0.05). The mean and median frequencies during the last 10 s
of the IE remained at the same level during the subsequent
sprints.
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FIGURE 3 | Power output. Peak (Wpeak-i) and mean (Wmean) power output during sprint exercise performed at the end of an incremental exercise to exhaustion in
normoxia (PIO2 ≈ 143mmHg) and severe hypoxia (PIO2 ≈ 73mmHg), after 10 or 60 s of occlusion of the circulation.
aP < 0.05 compared with the other conditions;
bP < 0.05 compared with Nx10s; cP < 0.05 compared with Nx60s.
TABLE 2 | Vastus lateralis electromyographic variables in response to sprint exercise performed at the end of an incremental exercise to exhaustion in
normoxia (PIO2 ≈ 143mmHg) and severe hypoxia (PIO2 ≈ 73mmHg), after 10 or 60 s of occlusion of the circulation.
Control sprint Nx10s Nx60s Hyp10s Hyp60s Main Oxy (P) Main Occ (P) Interaction
Oxy × Occ (P)
RMSraw (µV) 238.1±82.0a 153.2±64.7 137.1± 53.2 160.2± 68.7 161.8±61.8 0.220 0.706 0.429
RMSNz (A.U.) 475.1±155.2a 317.3±95.1 254.6± 110.0 344.2± 126.4c 317.0±172.4 0.112 0.059 0.436
Burst (ms) 331.9±24.6b,d 299.7±22.7c 324.6± 27.7 305.5± 23.8c 337.3±34.4b,d 0.026 0.001 0.381
TAINz (A.U.) 1023.1±340.6a 600.8±268.8 581.5± 244.2 642.9± 297.0 715.8±288.2 0.12 0.729 0.326
MPF (Hz) 93.9±9.7b,c 81.9±14.2 79.5± 16.4 86.3± 20.3 89.5±17.2 0.006 0.837 0.212
MdPF (Hz) 80.2±6.0b,c,d 66.4±9.4e 67.0± 13.6 71.4± 16.6 74.7±13.9c 0.011 0.255 0.500
aP < 0.05 compared with the other conditions.
bP < 0.05 compared with Nx10s.
cP < 0.05 compared with Nx60s.
dP < 0.05 compared with Hyp10s.
eP < 0.05 compared with Hyp60s.
RM ANOVA (2 × 2) Main Oxy: main oxygenation effect due to the conditions in which was performed the incremental exercise test (Nx, Normoxia; Hyp, hypoxia); RM ANOVA (2 × 2)
Main Occ, Main Occlusion effect due to the duration of the occlusion (10 vs. 60 s); Wpeak-i, instantaneous peak power in the sprint; Wmean, mean power in the 10 s sprint; RMSraw,
raw root mean square; RMSNz, Normalized root mean square; Burst, burst duration; TAINz, Normalized total activation index (arbitrary units, A.U.); MPF, mean power frequency; MdPF,
median power frequency.
The average RMS, RMSNz, and TAINz were 1.6-, 1.7-, and
2.9-fold higher during the sprints post-IE than during the last
10 s of the IE (all, P < 0.05). Compared to the control
sprints, the RMSraw and the normalized RMSNz were reduced
by 36 and 35%, respectively, in the sprints performed after
the IE (Table 2). Although the 60 s occlusion caused a 14%
lower RMSNz compared to the 10 s occlusion, this difference
did not reach statistical significance (Main effect P = 0.059).
Compared to the control sprints the TAINz was reduced by 42
and 34% during the sprints performed after the incremental test
in normoxia and hypoxia, respectively (P < 0.05).
Compared to the control sprint, the median frequency was
reduced by 18 and 9% in the sprints that followed the IEs in
normoxia and hypoxia, respectively (both, P < 0.05) (Table 3).
Thus, the median frequency was 9% lower in the sprints that
followed IE in normoxia than in hypoxia (Main effect P = 0.011).
MPF changes were essentially similar to MdPF (Tables 1–4).
Compared to the control sprints, the duration of the bursts
was reduced by 9% in the sprints performed after 10 s occlusions.
Nevertheless, after 60 s of occlusion, the duration of burst in the
following sprints achieved the same value as in the control sprints
(331.9 ± 24.6 and 331.0 ± 29.7ms, control and 60 s after IE,
respectively, P = 0.91). The duration of the bursts was 3% longer
in the sprints that followed an IE in hypoxia than normoxia
(P = 0.03). The average contraction time (i.e., burst duration
x pedaling rate) was 15% lower during the last 10 s of IE than
during the post-IE sprints (P < 0.001).
Vastus Medialis EMGs
The vastus medialis EMG responses to incremental (Table 1)
and sprint exercise (Table 3) were similar to those described for
the vastus lateralis. Therefore, we combined both vastus EMGs
responses to reduce variability (Table 4). The combined response
was similar to that reported for vastus lateralis and medialis, but
with lower variability, confirming some of the effects that did not
reach statistical significance when only analyzed using a single
muscle EMG recordings.
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TABLE 3 | Vastus medialis electromyographic variables in response to sprint exercise performed at the end of an incremental exercise to exhaustion in
normoxia and severe hypoxia (PIO2 ≈ 73mmHg), after 10 or 60 s of occlusion of the circulation.
Control sprint Nx10s Nx60s Hyp10s Hyp60s Main Oxy (P) Main Occ (P) Interaction
Oxy × Occ (P)
RMSraw (µV) 263.5± 115.7b,c,e 177.4±95.0d 193.9±121.3 204.2±103.1 183.9±81.1 0.333 0.943 0.038
RMSNz (A.U.) 410.4± 163.3a 284.0±97.1d 276.4±126.1 333.0±143.1 279.7±104.8d 0.078 0.137 0.098
Burst (ms) 342.2± 27.7b 309.4±42.5c 355.2±49.4d 322.0±53.1 347.8±37.9b 0.743 0.017 0.154
TAINz (A.U.) 1152.1± 463.3a 701.1±359.9d 809.0±498.6 829.7±397.9 820.7±335.6 0.118 0.638 0.119
MPF (Hz) 94.3± 9.9b,c,d 81.9±14.0 79.8±15.8 85.8±19.2 89.4±17.4 0.008 0.703 0.241
MdPF (Hz) 80.8± 6.7a 66.2±9.2 67.1±13.4 71.3±16.6 74.6±14.1b,c 0.011 0.218 0.587
aP < 0.05 compared with the other conditions.
bP < 0.05 compared with Nx10s.
cP < 0.05 compared with Nx60s.
dP < 0.05 compared with Hyp10s.
eP < 0.05 compared with Hyp60s.
RM ANOVA (2 × 2) Main Oxy, main oxygenation effect due to the conditions in which was performed the incremental exercise test (Nx, Normoxia; Hyp, hypoxia); RM ANOVA (2 × 2)
Main Occ, Main Occlusion effect due to the duration of the occlusion (10 vs. 60 s); RMSraw, raw root mean square; RMSNz, Normalized root mean square; Burst, burst duration; TAINz,
Normalized total activation index (arbitrary units, A.U.); MPF, mean power frequency; MdPF, median power frequency.
TABLE 4 | Electromyographic variables (average of vastus medialis and lateralis) in response to sprint exercise performed at the end of an incremental
exercise to exhaustion in normoxia (PIO2 ≈ 143mmHg) and severe hypoxia (PIO2 ≈ 73mmHg), after 10 or 60 s of occlusion of the circulation.
Control Nx10s Nx60s Hyp10s Hyp60s Main Oxy (P) Main Occ (P) Interaction
Oxy × Occ (P)
RMSraw (µV) 250.8± 89.1a 165.3±69.6d 165.5±76.5 182.2±79.8 172.9±50.7 0.164 0.793 0.536
RMSNz (A.U.) 442.7± 141.9a 300.6±88.9d 265.5±93.9d 338.6±122.7 298.3±117.7d 0.042 0.043 0.835
Burst (ms) 337.1± 23.9b,d 304.5±29.8c 339.9±36.0d 313.7±36.0 342.6±35.3b,d 0.305 0.005 0.754
TAINz (A.U.) 1089.7± 355.0 653.1±274.8d 720.1±323.5 739.6±331.4 769.7±238.9 0.082 0.510 0.575
MPF (Hz) 94.1± 9.8b,c,d 81.9±14.1 79.6±16.1 86.0±19.7 89.5±17.3b,c 0.007 0.769 0.221
MdPF (Hz) 80.5± 6.3b,c,d 66.3±9.2 67.0±13.5 71.3±16.6 74.6±14.0b,c 0.011 0.234 0.543
aP < 0.05 compared with the other conditions.
bP < 0.05 compared with Nx10s.
cP < 0.05 compared with Nx60s.
dP < 0.05 compared with Hyp10s.
RM ANOVA (2 × 2) Main Oxy, main oxygenation effect due to the conditions in which was performed the incremental exercise test (Nx, Normoxia; Hyp, hypoxia); RM ANOVA (2 × 2)
Main Occ, Main Occlusion effect due to the duration of the occlusion (10 vs. 60 s); RMSraw, raw root mean square; RMSNz, Normalized root mean square; Burst, burst duration; TAINz,
Normalized total activation index (arbitrary units, A.U.); MPF, mean power frequency; MdPF, median power frequency.
Muscle Metabolites
Muscle metabolites and the aerobic and anaerobic energy yield
during the sprints have been reported elsewhere (Morales-
Alamo et al., 2015). Briefly, ATP and PCr concentrations were
reduced to a similar extent both in normoxia and hypoxia
(ANOVA time effect: P < 0.05). From the 10th to 60th s
of ischemic recovery ATP concentration remained unchanged
while PCr declined an additional ∼5% (ANOVA time effect:
P < 0.05 compared to Post and P < 0.001, compared to
PRE). Muscle lactate concentration was increased to similar
values 10 s after both incremental exercise tests (93.5 ± 24.3
and 88.3 ± 26.6mmol kg d.w.−1, in normoxia and hypoxia,
respectively (ANOVA time effect: P < 0.001). From the
10th to 60th s of ischemia muscle lactate was increased by
24.0 ± 20.7 and 21.6 ± 24.5mmol kg d.w.−1, and muscle pH
reduced by 0.102 ± 0.040 and 0.109 ± 0.041 units, after the
IE in normoxia and hypoxia, respectively (ANOVA time effect:
P < 0.01).
DISCUSSION
This investigation confirms, in agreement with previous studies
using constant intensity (Marcora and Staiano, 2010) and
incremental exercise to exhaustion in normoxia (Coelho et al.,
2015), that task failure during incremental exercise in normoxia
is not caused by muscle fatigue. The present study extends these
findings to whole-body incremental exercise in severe hypoxia.
We have also shown that muscle activation during the last 10 s of
an incremental exercise to exhaustion is lower in severe hypoxia
than in normoxia. This reduction in muscle activation cannot
be explained by differences in metabolite accumulation between
hypoxia and normoxia, and likely reflects central mechanisms
of fatigue, which recovered, at least partly, during the next 10
or 60 s of ischemia, as reflected by the greater activation of the
muscles during the subsequent sprint. The latter occurred despite
the lower energy availability and the greater accumulation of
metabolites after the ischemic recoveries. We have shown that
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neuromuscular performance, as assessed by a sprint test, at the
end of an incremental exercise to exhaustion, is greater when
the incremental exercise has been performed in severe acute
hypoxia than in normoxia despite similar muscle metabolite
accumulation. This is also compatible with the incremental
exercise in hypoxia ending by central mechanism/s acting earlier,
i.e., with a lower amount of peripheral fatigue in hypoxia than in
normoxia. This reduction in sprint performance is accompanied
by a greater reduction in muscle activation (as reflected by the
EMGRMS changes) in the sprints carried out after IE in normoxia
than hypoxia. This could also be interpreted as indicative of
slower recovery of central mechanisms of fatigue during the 10 s
of ischemic recovery that followed the IE performed in normoxia
compared to the sprint performed after the IE in hypoxia.
Strikingly, following 60 s of recovery with complete occlusion
of the circulation sprint performance was higher than that
observed immediately following 10 s of occlusion, as previously
reported (Morales-Alamo et al., 2015). This improvement in
performance was achieved with lower EMGRMS compared to the
sprints executed after 10 s of ischemia. Thus, this investigation
demonstrates dissociation between the recovery of the EMGRMS
and the recovery of power output. Since occlusion resulted in an
increase ofmuscle lactate andH+ accumulation from 10 to 60 s of
occlusion (Morales-Alamo et al., 2015), the present experiments
support the concept that muscle acidification contributes to
reduce EMGRMS. In addition, we have demonstrated that despite
similar muscle concentrations of lactate and H+ at the beginning
of the respective sprints, the MPF and MdPF during sprint
exercise are reduced by muscle fatigue when the sprint is
performed after an incremental exercise in normoxia, but not in
hypoxia. MPF and MdPF did not recover from the end of the
incremental exercise to the start of the sprints, or from the 10th to
the 60th second of ischemia, despite cessation of neural activation
and appropriate oxygenation of the brain. These results point
to peripheral mechanisms being primarily responsible for the
reduction of MPF and MdPF during the sprints post-IE (Juel,
1988; Brody et al., 1991). Moreover, despite greater lactate
and H+ accumulation after 60 s of ischemic recovery, sprint
exercise MPF and MdPF were not further reduced; therefore
these two metabolites do not seem to account for the observed
reduction of MPF and MdPF with muscle fatigue (Vestergaard-
Poulsen et al., 1995). We have also shown that the duration
of the bursts is reduced in fatigued muscles contracting under
isokinetic conditions, recovering to non-fatigued levels within
60 s, regardless of the muscular concentrations of lactate and
H+. We lastly provided evidence for a minor impact, if any,
of increased group III/IV afferent feedback on sprint exercise
performance.
Surface EMG Changes are More Sensitive
to Central than Peripheral Fatigue
To demonstrate the existence of central fatigue it is necessary
to show that during a maximal voluntary contraction, direct
stimulation of motor neural pathways or cortical motoneurons
results in greater levels of force than elicited voluntarily (Merton,
1954; Gandevia et al., 1996). These procedures have several
constraints limiting their application to complex tasks, such
as pedaling. To circumvent these problems, a commonly used
approach has been to carry out potentiated and interpolated
twitch assessments at exhaustion as fast as possible, i.e., 1–2min
after the task failure, when most of the reduction in power
output has already been recovered (Sargeant and Dolan, 1987;
Fernandez-del-Olmo et al., 2013; Froyd et al., 2013; Coelho
et al., 2015). Another limitation of stimulation techniques is
that muscle fatigue is task-specific (Gandevia, 2001). Stimulation
techniques cannot reproduce the complexity of motor orders
involving thousands of motor units from different muscles firing
at different rates, which are recruited with specific timings to
achieve a coordinated movement. Also, in fatigued muscles, the
increase in force elicited by an interpolated twitch may be due
in part to intracellular mechanisms (i.e., a peripheral mechanism
that is likely related to the force/[Ca2+]i relationship) (Gandevia
et al., 2013), not necessarily reflecting increased central fatigue.
An alternative approach for assessing muscle fatigue is to
measure the maximal power that can be generated during the
task that elicits muscle fatigue (Cairns et al., 2005; Marcora
and Staiano, 2010; Coelho et al., 2015). However, during
whole-body exercise on the cycle ergometer, pedaling frequency
slows down close to task failure (Torres-Peralta et al., 2014).
Given the dependency of power on muscle contraction velocity,
fatigue should ideally be tested under similar muscle contraction
velocities as during isokinetic pedaling (Sargeant and Dolan,
1987).
In the present experiments, the sprints were performed
in isokinetic conditions, i.e., the duration of each pedaling
cycle was always the same, regardless of the state of muscle
fatigue (Figure 2). This isokinetic approach was possible because
the cycle ergometer servo-control instantaneously varied the
resistance applied to the pedals depending on the force exerted
resulting in a constant pedaling rate of 80 rpm. These conditions
allowed us to examine the impact of fatigue on certain
components of the EMG signal without the variability induced
by the speed of movement.
At a given pedaling rate, the duration of contraction bursts
increases with the intensity of exercise, reaching maximal values
at intensities close to Wmax (Torres-Peralta et al., 2014). In all
conditions and every subject, the mean intensity achieved during
the 10 s sprints was above the intensity reached at exhaustion
during the IEs. This result implies that concerning intensity, burst
duration should have been maximal during all sprints. However,
burst duration during the sprints performed after 10 s of ischemic
recovery was reduced, meaning that muscles were activated
during a shorter fraction of the pedaling cycle compared to the
control sprints. This effect might have been caused by reduced
sarcolemmal excitability as a consequence of fatigue (Sejersted
and Sjogaard, 2000; Sidhu et al., 2012). Reduced sarcolemmal
excitability during hand grip exercise has been associated with
lactic acidosis in blood (Hilbert et al., 2012). However, if present
at exhaustion, sarcolemmal excitability appears to recover in
less than 60 s after a fatiguing sprint exercise (Fernandez-del-
Olmo et al., 2013). In agreement, burst duration recovered within
the 60 s of ischemic rest after both IEs. Despite the observed
recovery of burst duration, the EMGRMS was further reduced
following 60 s of ischemia. Since the reduction in EMGRMS
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was accompanied by increased power output and normal burst
duration, it seems unlikely that the lower sprint EMGRMS after
60 s of ischemia originates from a failure of the muscle cells to
respond to neural activation.
During high-intensity contractions, the myosin ATPase and
ion pumps account for most of the energy expenditure inmuscles
because no energy can be diverted to biosynthetic processes
as the required enzymes are blocked (Morales-Alamo and
Calbet, 2014). In our experimental conditions, upon cessation of
incremental exercise the ion pumps are expected to be maximally
activated, particularly the Na+-K+ pump, which has a critical
role in restoring sarcolemmal excitability (Pedersen et al., 2003;
Hostrup et al., 2014). During ischemia, the energy needed to
maintain the activity of the ion pumps was provided by the
glycolysis and to a lesser extent by the minute amount of
remaining PCr (Morales-Alamo et al., 2015). The O2 that still
remained bound to myoglobin at the end of incremental exercise
was rapidly used upon occlusion due to the strong activation of
mitochondrial respiration by the increased ADP concentration at
task failure (Morales-Alamo et al., 2015). Femoral vein and mean
capillary PO2 were lower at exhaustion after the incremental
exercise test in severe hypoxia than in normoxia (Calbet et al.,
2015). Therefore, the potential contribution of the small amount
of O2 trapped in the occluded leg (or remaining bound to
myoglobin) to ATP re-synthesis should have been lower in
hypoxia than in normoxia. However, although more O2 was
available at exhaustion for the initial recovery in normoxia,
i.e., within the first 10 s of occlusion, performance was more
impaired in the sprint performed after 10 s of ischemic recovery
that followed the normoxic rather than the hypoxic IEs. This
result concurs with task failure occurring with a lower level of
peripheral fatigue during IE in hypoxia than normoxia, as our
results indicate.
Studies in cats (Hill et al., 1992; Lagier-Tessonnier et al.,
1993) and rabbits (Arbogast et al., 2000) have shown increased
baseline discharge frequency of group III and IV muscle
afferents by PO2 close to the values observed in the femoral
vein in the present investigation (Calbet et al., 2015). Thus,
lower interstitial PO2 values in hypoxia than normoxia could
have enhanced III/IV afferent feedback to cause increased
inhibition of the corticospinal drive during exercise in severe
acute hypoxia, as previously suggested (Calbet et al., 2015).
Muscle III and IV afferent, and perhaps other sensory endings
in joints and tendons, have been postulated to contribute
to central fatigue (Reid, 1927; Bigland-Ritchie et al., 1986;
Garland, 1991; Amann et al., 2008, 2013a). Animal studies
have shown that when motoneurons are stimulated repetitively
many neurons reduce their discharge frequency or stop firing
(Kernell and Monster, 1982a,b; Spielmann et al., 1993). This
phenomenon is likely accentuated by hypoxia. Consequently,
reduced responsiveness of some motoneurons pools (central
fatigue) combined with increased III/IVmuscle afferent feedback
and increased ventilatory demand at any given absolute intensity
might have increased the perception of effort (Marcora, 2009),
leading to task failure at the end of IE in hypoxia with a lower
level of peripheral fatigue than in normoxia (Pierrefiche et al.,
1997). Oxygenation upon exhaustion might have restored faster
central fatigue at the end of the IE in hypoxia than normoxia,
by reinstating within seconds normoxic interstitial PO2 levels
in the CNS. In agreement, with altitude acclimatization, oxygen
delivery at VO2max is almost restored to sea level values (Calbet
and Lundby, 2009), improving brain oxygenation compared to
acute hypoxia and reducing supraspinal fatigue (Goodall et al.,
2014a,b).
The absolute exercise intensity at task failure was lower in
hypoxia than normoxia. However, metabolite accumulation was
similar regardless of FIO2 and, hence, differences in absolute
exercise intensity do not seem to account for the differences in
peripheral fatigue.
Group III and IV Muscle Afferent
Stimulation does not Limit Peak Power
Output during Whole-Body Sprint Exercise
in Healthy Humans
Group III/IV muscle afferent neurons include a complex family
of afferent endings some of which act as nociceptors while others
respond to thermal, mechanical or chemical stimulation (Light
et al., 2008; McCord and Kaufman, 2010; Jankowski et al., 2013).
Metabolic products of muscle contraction like H+ (Rotto and
Kaufman, 1988; Light et al., 2008), lactate (Light et al., 2008),
adenosine (Middlekauff et al., 1997), ATP (Light et al., 2008),
nitric oxide (Arbogast et al., 2001), and inflammation mediators
may also increase III/IV muscle afferent discharge (Light et al.,
2008; McCord and Kaufman, 2010). It is particularly important
that the response to the isolated increase of H+, ATP and lactate is
much lower than observed to the combination of the three (Light
et al., 2008). Some metaboreceptive III and IV muscle afferents
seem specialized in detecting innocuous levels of metabolites,
while others respond to noxious levels and contribute to muscle
pain (Kniffki et al., 1978;Mense, 1996). It is thought that both low
and high concentration responding-endings could contribute to
sympathetic reflexes and to increase the perception of effort
(Light et al., 2008).
Using lumbar intrathecal fentanyl administration before
exercise to block µ-opioid receptor-sensitive group, Amann and
co-workers (Amann et al., 2009, 2011) studied the influence of
group III and IV afferents on voluntary activation (assessed by the
twitch-interpolation technique) after constant-intensity bicycling
exercise. After 3min of recovery, voluntary activation was
reduced by 1.2% during the placebo trial (non-significant) and
1.7% during the fentanyl trial (Amann et al., 2011). Moreover,
3min after a time trial that caused fatigue in 7.5min, voluntary
activation was reduced by 1.6% (compared to 0.8% in the placebo
trial) (Amann et al., 2009). These results further emphasize that
any potentially negative influence of III and IV muscle afferents
on voluntary activation is likely small after whole-body exercise
or that voluntary activation capacity recovers rather quickly
(Bigland-Ritchie et al., 1986; Kennedy et al., 2015; Pageaux et al.,
2015).
Amann et al. (2011) reported that despite the inhibition
of III and IV muscle afferents, fentanyl markedly reduced
performance (from 8.7 to 6.8min) during a constant-intensity
trial to exhaustion. In another study by the same group
Frontiers in Physiology | www.frontiersin.org 10 January 2016 | Volume 6 | Article 414
Torres-Peralta et al. Fatigue, Muscle Activation and Metaboreflex
(Amann et al., 2009), where the subjects performed a time
trial, performance was similar in the fentanyl and placebo
experiments. The reason for these discrepant effects of III/IV
muscle afferents inhibition on performance is not clear (Marcora,
2010). In the case of the constant-intensity trial, there was a
substantial impairment in O2 transport in the fentanyl trial, an
effect caused by reduced ventilation, leading to lower hemoglobin
saturation and VO2 with fentanyl than placebo. A slightly
lower impairment of O2 transport was reported in the time
trial experiments, which could have been compensated for by
increased involvement of the anaerobic metabolism (Amann
et al., 2009). Marcora (2010) have suggested that during the time
trial, the “belief effect” induced by reducing leg muscle pain
with fentanyl-induced a fast start, which compensated for the
negative effect of fentanyl on cardiorespiratory responses. As a
result, exercise performance was unchanged during the time trial.
During the constant-intensity trial, the “belief effect” could not
induce a fast start and consequently exercise performance was
reduced.
Interestingly, in both experiments with fentanyl the reduction
of quadriceps potentiated twitch forces elicited by magnetic
neural stimulation were greater than in the control trials (Amann
et al., 2009, 2011). Assuming that a reduction in the force
elicited by potentiated twitches indicates a greater level of
peripheral fatigue and that the subjects exercised to their limits
in all trials, Amann and co-workers studies give support to the
concept that III/IV afferent feedback is used to set the limit of
peripheral fatigue that is permitted. However, these experiments,
combined with the present findings, show that task failure at
the end of an IE to exhaustion (current study), or at the end
of constant-intensity (Marcora and Staiano, 2010; Bosio et al.,
2012) or a simulated time-trial competition (Amann and co-
workers studies) is not due to a peripheral failure. Both types
of experiments show that greater levels of peripheral fatigue
are possible, but not reached because the exercise ends due
to central mechanisms of fatigue (Kayser, 2003). The critical
question is whether peripheral fatigue causes central fatigue
and task failure through a central mechanism by activating
the metaboreflex. If the latter is the main mechanism causing
central fatigue and task failure a reduction in sprint performance
under conditions with increased metaboreflex activation will
be expected. However, our results show that this is not the
case.
Metabolite accumulation at task failure and during ischemia
should have promoted a sustained discharge of III/IV muscle
afferents (Darques and Jammes, 1997; Darques et al., 1998; Light
et al., 2008; McCord and Kaufman, 2010), an effect that would
be expected to be greater after 60 than 10 s occlusions in the
present investigation. Nevertheless, sprint exercise power output
was higher after 60 than 10 s of ischemia. Increased metaboreflex
activation should exacerbate the ventilatory response to exercise
(Amann et al., 2010), as observed during the sprints performed
following 60 s of ischemia in the present investigation (Morales-
Alamo et al., 2015). Thus, despite increased metaboreflex
activation during the sprints after 60 s of ischemia, and a
theoretically worsenedmetabolic situation, peak andmean power
output was higher during the sprints after 60 than 10 s of
ischemia. Our findings appear to be at odds with the recent
study by Kennedy et al. (2015), in which the occlusion of
the circulation during 2min after a 2-min sustained MVC
of the knee extensors resulted in a progressive reduction of
the maximal voluntary contraction (MVC) (see Figure 3A
of Kennedy et al., 2015). This effect was accompanied by a
progressive reduction of maximal voluntary activation indicative
of increasing central fatigue (see Figure 3B of Kennedy et al.,
2015). In agreement with our results, Kennedy et al. (2015)
observed a fast recovery of voluntary activation upon release
of the cuff, indicating that the negative influence of III/IV
afferent discharge on voluntary activation was also relieved
very rapidly. This quick response could be due to (i) the
release of the direct compression on the femoral nerve, (ii)
the washout of metabolites combined with oxygenation due to
reactive hyperemia, or (iii) the combination of these effects.
In our experimental conditions, the hyperemic response to the
release of the cuff was likely much greater than in Kennedy
et al. (2015) as reflected by the rapid increase of pulmonary
VO2 and the elevated heart rate at the beginning of the sprint
(Morales-Alamo et al., 2015). Another interesting aspect of the
study by Kennedy et al. (2015) is that the level of peripheral
fatigue as assessed by potentiated twitches remained at the
same level during the 2min of ischemia, despite 5 × 2-s long
MVC maneuvers (i.e., 10 s of maximal contractile activity with
occlusion of the circulation). Thus, the 2min of post-exercise
ischemia did not worsen peripheral fatigue (Kennedy et al.,
2015). Although Kennedy et al. (2015) did not measure muscle
metabolites, 10 s of maximal contractile activity during the 2min
of ischemia, in combination with increased metabolic demand
due to the preceding MVC (sustained during 2min), should
have increased peripheral fatigue according to the prevailing
paradigm.
The present investigation strongly suggests that the inhibitory
role of muscle afferent discharge on the corticospinal motor
drive during maximal intensity whole-body exercise is either
small or counteracted by a strong corticospinal drive (central
command). Otherwise, the III/IV muscle afferent feedback
due to ischemia (PO2 close to 0mmHg in our experimental
conditions) and the metabolites accumulated during the IEs
should have decreased Wpeak and Wmean during the 10 or
60 s post-ischemia sprints below the Wmax achieved at task
failure in the IEs. This finding contrasts with experiments
using single joint (Gandevia et al., 1996; Kennedy et al., 2015)
or handgrip dynamic contractions (Broxterman et al., 2015),
where a clear inhibition of voluntary activation is consistently
shown.
In the present investigation, increased III/IV muscle afferent
feedback could explain why the observed EMGRMS were lower
in the sprints performed after 60 s than after 10 s of ischemia.
Likewise, that MPF and MdPF remained at task failure levels
during the post-IE sprints is also consistent with an on-going
negative feedback reducing motoneurons firing frequencies
(Broxterman et al., 2015). However, the power output achieved
during the sprints after 60 s of ischemia is close to the maximal
power attainable by our subjects without phosphagens (Morales-
Alamo et al., 2015), leaving little room for central mechanisms
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to limit sprint performance after 60 s of ischemia. Thus, it
seems that 60 s of ischemic recovery allows for restoration of
the central mechanisms of fatigue, despite the discharge from
the III/IV muscle afferents. The latter was likely counteracted
by a strong central command and a rapid reperfusion of
the muscle upon the release of the cuff during the post-IE
sprints. In agreement with this interpretation, Amann et al.
(2009) reported no effect of intrathecal fentanyl on time trial
performance, although the power output profile was dramatically
changed.
Reduced Sprint EMGRMS But Increased
Power Output after 60 than 10 s
Post-Exercise Ischemia
In vitro experiments have shown that lactate and H+
accumulation may facilitate peripheral recovery by increasing
chloride conductance (Nielsen et al., 2001; Pedersen et al.,
2003; Karelis et al., 2004). Thus, an elevated glycolytic rate
combined with a progressive rise of muscle temperature due
to flow arrest during ischemic recovery could have exerted
two opposing actions. Positively, increased glycolysis may
have facilitated peripheral recovery by enhancing sarcolemmal
excitability (Pedersen et al., 2003), which was likely depressed
immediately after the IEs. Negatively, increased glycolysis and
the subsequent metabolite accumulation may have increased
III/IV muscle afferent discharge, interfering with muscle
activation. The combination of both mechanisms could
explain the lower EMGRMS values observed during the sprints
performed 60 s compared to 10 s after the IEs. If we assume
that the normalized EMGRMS is a valid index of corticospinal
motor output, only reduced when the corticospinal motor
drive is lower, a greater reduction in sprint EMGRMS after
prolonged (60 s) compared to shorter (10 s) ischemia would
lead to the untenable conclusion that all of the improvement
in Wpeak and Wmean observed from 10 to 60 s of ischemic
recovery is due to peripheral mechanisms. Moreover, this
peripheral-based improvement would have to be sufficient to
counteract the reduced motor command. A more plausible
explanation is that for a given level of neural activation, EMGRMS
is reduced by metabolite accumulation; i.e., EMGRMS does not
faithfully reflect the level of neural activation (Vestergaard-
Poulsen et al., 1995). In agreement with this interpretation,
it has been shown that central fatigue recovers rapidly upon
cessation of contractile activity, even when peripheral fatigue
remains at the same level (Bigland-Ritchie et al., 1986; Gandevia
et al., 1996). Therefore, the observed reduction in sprint
EMGRMS after 60 s compared to 10 s of ischemic recovery is
unlikely to be caused only by increased central mechanisms of
fatigue.
Fatigue Reduces the Duration of the Burst
during Isokinetic Sprints
The duration of the burst was similarly decreased in the sprints
performed 10 s after the incremental exercise in hypoxia and
normoxia. However, sprint power output was greater after the
incremental exercise in hypoxia. To generate greater power, more
mechanical impulse must be produced. As the duration of the
bursts (a surrogate of contraction time) was similar in the sprints
performed 10 s after both IEs, the subjects must have applied a
greater force on the pedals after the hypoxic IE. Therefore, greater
motor cortical drive was required in the sprint that occurred
after hypoxia. In agreement, with this conclusion, the MPF and
MdPF were higher in the sprints preceded by IE in hypoxia than
normoxia, suggesting greater firing rates (Solomonow et al., 1990;
Gerdle and Fugl-Meyer, 1992; Sbriccoli et al., 2003) and a lower
degree of central fatigue during the sprint 10 s after the IE in
hypoxia. Alternatively, central fatigue could have recovered more
rapidly after the IE in hypoxia, likely due to a direct effect of
oxygenation on the CNS, as previously postulated (Kayser et al.,
1994; Calbet et al., 2003a,b; Amann et al., 2007; Goodall et al.,
2014a).
Limitations
At the end of the incremental exercise muscle activation was
much lower than during the subsequent sprints, despite the fact
muscles remained ischemic and that metabolite accumulation
reduces EMGRMS. This finding indicates that task failure
was not due to muscle fatigue; it was caused by reduced
muscle activation. However, this conclusion is not based on
genuine assessments of central fatigue and peripheral fatigue
with stimulation techniques. Nonetheless, there is not an ideal
method to quantify the extent of change in neuromuscular
function (Cairns et al., 2005). Current methods based on
stimulation techniques have also limitations. For example, the
response of fatigued muscles to potentiated twitches depends
on the method of stimulation (Froyd et al., 2013). Moreover,
methods based on electrical or magnetic stimulation may
give results different from those obtained using voluntary
dynamic contractions. Few minutes after a 30 s all out sprint
exercise (Wingate test) potentiated quadriceps twitches indicate
substantial peripheral fatigue, when at the same time peak power
output has completely recovered (Fernandez-del-Olmo et al.,
2013).
In summary, task failure at the end of an incremental
exercise to exhaustion depends more on central than peripheral
mechanisms, as indicated by the fact that the level of muscle
activation observed during the last 10 s of the incremental
exercise was much lower than that reached 10 s later during
a 10 s sprint, despite the fact that muscle remained ischemic
from the end of exercise to the start of the sprint. The
central components of fatigue appear to recover to a greater
extent, during the first 10 s following an incremental exercise
to exhaustion in hypoxia than in normoxia, concomitant with
a rapid change to normoxic breathing during the recovery.
We have also shown that ischemic recovery after incremental
exercise to exhaustion allows for a partial restoration of power
output despite increased acidification and reduced EMGRMS.
Moreover, this study demonstrates that MPF, MdPF and the
duration of the bursts during isokinetic sprints are reduced
with fatigue. Lastly, this investigation indicates that increased
group III/IV muscle afferent discharge has a minor, if any,
negative impact on sprint exercise performance in healthy
humans.
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